Study Of PF-06410293 And Adalimumab In Healthy Subjects (REFLECTIONS B538-01)

NCT01870986 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: PF-06410293
BIOLOGICAL: Humira (adalimumab-EU)
BIOLOGICAL: Humira (adalimumab-US)

Sponsor

Pfizer